FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

HS Jaffe

Research Profile

Chemicals & Drugs

Disorders

Procedures

Concepts & Ideas

Biological Availability

Living Beings

Co-author Network

Publications

TOP 3
Richard Gilson; K B Chopra; A M Newell; I M Murray-Lyon; M R Nelson; S J Rice; Richard S Tedder; J Toole; HS Jaffe; I V D Weller
A placebo-controlled phase I/II study of adefovir dipivoxil in patients with chronic hepatitis B virus infection.
Kenneth C Cundy; PATRICIA CROVO; Brent G Petty; A Ruby; M Redpath; HS Jaffe; Paul S Lietman
Clinical pharmacokinetics of 1-[((S)-2-hydroxy-2-oxo-1,4,2-dioxaphosphorinan-5-yl)methyl]cytosine in human immunodeficiency virus-infected patients.
S Safrin; Julie M Cherrington; HS Jaffe
Cidofovir. Review of current and potential clinical uses.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of HS Jaffe (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

1999: Richard Gilson; K B Chopra; A M Newell; I M Murray-Lyon; M R Nelson; S J Rice; Richard S Tedder; J Toole; HS Jaffe; I V D Weller
A placebo-controlled phase I/II study of adefovir dipivoxil in patients with chronic hepatitis B virus infection.
Journal of viral hepatitis 1999;6(5):387-95.
1999: Kenneth C Cundy; PATRICIA CROVO; Brent G Petty; A Ruby; M Redpath; HS Jaffe; Paul S Lietman
Clinical pharmacokinetics of 1-[((S)-2-hydroxy-2-oxo-1,4,2-dioxaphosphorinan-5-yl)methyl]cytosine in human immunodeficiency virus-infected patients.
Antimicrobial agents and chemotherapy 1999;43(2):271-7.
1999: S Safrin; Julie M Cherrington; HS Jaffe
Cidofovir. Review of current and potential clinical uses.
Advances in experimental medicine and biology 1999;458():111-20.
1998: Stephen L Sacks; Stephen D Shafran; Francisco Diaz-Mitoma; Sylvie Trottier; R G Sibbald; A Hughes; S Safrin; J Rudy; B McGuire; HS Jaffe
A multicenter phase I/II dose escalation study of single-dose cidofovir gel for treatment of recurrent genital herpes.
Antimicrobial agents and chemotherapy 1998;42(11):2996-9.
1998: Jacob P Lalezari; Gary N Holland; F Kramer; G F McKinley; C A Kemper; D V Ives; R Nelson; W David Hardy; Baruch D Kuppermann; Donald W Northfelt; M Youle; M Johnson; Richard Alan Lewis; David V Weinberg; G L Simon; Richard A Wolitz; A E Ruby; R J Stagg; HS Jaffe
Randomized, controlled study of the safety and efficacy of intravenous cidofovir for the treatment of relapsing cytomegalovirus retinitis in patients with AIDS.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1998;17(4):339-44.
1997: Steven G Deeks; A Collier; Jacob P Lalezari; A Pavia; D Rodrigue; W Lawrence Drew; J Toole; HS Jaffe; Andrew S Mulato; PD Lamy; W Li; Julie M Cherrington; Nicholas S Hellmann; J Kahn
The safety and efficacy of adefovir dipivoxil, a novel anti-human immunodeficiency virus (HIV) therapy, in HIV-infected adults: a randomized, double-blind, placebo-controlled trial.
The Journal of infectious diseases 1997;176(6):1517-23.
1997: Jacob P Lalezari; T Schacker; J Feinberg; J Gathe; S Lee; T Cheung; F Kramer; H Kessler; L Corey; W Lawrence Drew; J Boggs; B McGuire; HS Jaffe; S Safrin
A randomized, double-blind, placebo-controlled trial of cidofovir gel for the treatment of acyclovir-unresponsive mucocutaneous herpes simplex virus infection in patients with AIDS.
The Journal of infectious diseases 1997;176(4):892-8.
1997: PATRICIA CROVO; J Toole; Craig W Hendrix; Kenneth C Cundy; D Ebeling; HS Jaffe; Paul S Lietman
Anti-human immunodeficiency virus (HIV) activity, safety, and pharmacokinetics of adefovir dipivoxil (9-[2-(bis-pivaloyloxymethyl)-phosphonylmethoxyethyl]adenine) in HIV-infected patients.
The Journal of infectious diseases 1997;176(2):406-13.
1997: Jacob P Lalezari; R J Stagg; Baruch D Kuppermann; Gary N Holland; F Kramer; D V Ives; M Youle; M R Robinson; W Lawrence Drew; HS Jaffe
Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS. A randomized, controlled trial.
Annals of internal medicine 1997;126(4):257-63.
1996: M Wachsman; Brent G Petty; Kenneth C Cundy; HS Jaffe; P E Fisher; A Pastelak; Paul S Lietman
Pharmacokinetics, safety and bioavailability of HPMPC (cidofovir) in human immunodeficiency virus-infected subjects.
Antiviral research 1996;29(2-3):153-61.
1996: Jacob P Lalezari; R J Stagg; HS Jaffe; M J Hitchcock; W Lawrence Drew
A preclinical and clinical overview of the nucleotide-based antiviral agent cidofovir (HPMPC).
Advances in experimental medicine and biology 1996;394():105-15.
1995: Kenneth C Cundy; PATRICIA CROVO; Robert E Walker; A C Collier; D Ebeling; J Toole; HS Jaffe
Clinical pharmacokinetics of adefovir in human immunodeficiency virus type 1-infected patients.
Antimicrobial agents and chemotherapy 1995;39(11):2401-5.
1995: Kenneth C Cundy; Brent G Petty; J Flaherty; P E Fisher; Michael A Polis; M Wachsman; Paul S Lietman; Jacob P Lalezari; M J Hitchcock; HS Jaffe
Clinical pharmacokinetics of cidofovir in human immunodeficiency virus-infected patients.
Antimicrobial agents and chemotherapy 1995;39(6):1247-52.
1995: Michael A Polis; K M Spooner; B F Baird; J F Manischewitz; HS Jaffe; P E Fisher; Judith Falloon; Richard Davey; Joseph A Kovacs; Robert E Walker
Anticytomegaloviral activity and safety of cidofovir in patients with human immunodeficiency virus infection and cytomegalovirus viruria.
Antimicrobial agents and chemotherapy 1995;39(4):882-6.
1994: Jacob P Lalezari; W Lawrence Drew; E Glutzer; D Miner; S Safrin; W F Owen; J M Davidson; P E Fisher; HS Jaffe
Treatment with intravenous (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]-cytosine of acyclovir-resistant mucocutaneous infection with herpes simplex virus in a patient with AIDS.
The Journal of infectious diseases 1994;170(3):570-2.
1989: Kim Margolin; A A Rayner; M J Hawkins; Michael B Atkins; Janice P Dutcher; Richard I Fisher; G R Weiss; James Doroshow; HS Jaffe; M Roper
Interleukin-2 and lymphokine-activated killer cell therapy of solid tumors: analysis of toxicity and management guidelines.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(4):486-98.
1988: B T Gemlo; M A Palladino; HS Jaffe; T P Espevik; A A Rayner
Circulating cytokines in patients with metastatic cancer treated with recombinant interleukin 2 and lymphokine-activated killer cells.
Cancer research 1988;48(20):5864-7.